Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol

Authors:

Abstract
The treatment of acute lymphoblastic leukemia (ALL) is frequently complicated by toxicity, including venous thromboembolism (VTE) affecting roughly 8% of patients. VTE can lead to post‐thrombotic syndrome (PTS), a group of signs and symptoms developed as a complication to deep venous thrombosis (DVT), imposing risk of permanent disability and reduced quality of life (QoL). PTS prevalence ranges from 0% to 70%, reflecting very heterogenous cohorts and assessment tools. We aimed to estimate sequelae, including PTS and QoL in children and adults (p = .9). This study underscores the need for comprehensive population‐based investigations with validation of PTS instruments in ALL survivors.
Funding Information
  • Børnecancerfonden (2018‐3682, 2020‐6755)
  • Farmer of Oelufgaard Memorial Foundation
  • Grosserer M. Brogaard og Hustrus Mindefond

This publication has 31 references indexed in Scilit: